Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

16.76 USD -0.98 (-5.52%)
Official Closing Price Updated: 7:57 PM EDT, Oct 28, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,071,400
Open 17.26
Bid (Size) 16.80 (30)
Ask (Size) 16.98 (7)
Prev. Close 17.74
Today's Range 16.75 - 17.36
52wk Range 11.15 - 31.97
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the introduction of the SimplifEYE™ intraocular lens (IOL)... 
From PR Newswire
Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest dermatology health care businesses in the world, today announced the presentation of... 
From PR Newswire

Performance

YTD
-43.72%
-43.72%
1 Month
+9.76%
+9.76%
3 Month
-11.97%
-11.97%
6 Month
-8.86%
-8.86%
1 Year
-31.51%
-31.51%

More News

Read More
Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting
From PR Newswire
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
From PR Newswire
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million
From GlobeNewswire News Releases
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12
From PR Newswire
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020
From PR Newswire
Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery
From PR Newswire
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb Infuse™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Optometry Annual
From PR Newswire
Salix Supports Liver Awareness Month With New Educational Initiatives
From PR Newswire
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.